No Picture

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the […]


Exclusive: AstraZeneca signs off on a ‘carbon negative’ new biotech building for one of its latest buyouts

Breakthrough Properties is back keeping the dirt flying in biotech — this time breaking new ground in Amsterdam. The commercial real estate alliance between Tishman Speyer, which built Pfizer’s new world headquarters in Manhattan, and […]